Top Markets
#1 Akedo Akedo +64.36%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.34%
#4 Cross Cross +45.41%
#5 Black Phoenix Black Phoenix +34.24%
#6 Velvet Velvet +30.05%
#7 OVERTAKE OVERTAKE +26.38%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.75%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.03%
#10 Palladium Network Palladium Network +12.84%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
E-therapeutics Plc E-therapeutics Plc

E-therapeutics Plc

ETX
Rang in Aktien #38859
E-therapeutics Plc, established in 2001 and headquartered in London, UK, is a... E-therapeutics Plc, established in 2001 and headquartered in London, UK, is a drug discovery research company. It employs an advanced computational platform that conducts in silico screening to forecast compounds and biological targets capable of profoundly altering biological systems, drawing insights from its proprietary network models. Additionally, the firm is developing an RNA interference (RNAi) platform aimed at achieving highly specific gene silencing.
Aktienkurs
$0.12246314
Zuletzt synchronisiert: 2024-05-08
Marktkapitalisierung
$767.28K
Veränderung (1 Tag)
1.50%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel E-therapeutics Plc (ETX)

Kategorie

Healthcare
Dividendenrendite-Verlauf für E-therapeutics Plc (ETX)
Dividendenrendite (TTM) von E-therapeutics Plc (Aktienkürzel: ETX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für E-therapeutics Plc (ETX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE